Pharma naming is no place for name bias.

Case Study: Repatha
Sometimes the question isn’t: What should I call it? The question is: Can I call it this? Read on. »


Keeping quality high when time is tight.

Case Study: ClickWell
Stanford Health Care needed a product name, and they needed it fast. Read on. »


Meeting tomorrow's needs today.

Case Study: GSK Pipeline
Zenmark specializes in multiple-asset naming projects. For GlaxoSmithKline, this meant encompassing the entire pipeline. Nearly a year later, GSK had a set of candidates that met global legal and discriminating creative requirements. Read on. »

GSK Pipeline

More Dell, less names.

Case Study: Dell
Strategy solves for today and plans for tomorrow. From mobile to server, storage to solutions, and consumer to commercial we’ve created everything from names to nomenclature to help bring order and simplicity to Dell’s entire portfolio. Read on. »


Making technical sound accessible.

Case Study: Panorama
Scientific naming poses unique challenges. For Natera, we balanced technical accuracy and simplicity in naming a prenatal test. Our name, Panorama, captured the expansive view this treatment brings to pregnant couples. Read on. »


Bringing our "A" game at crunch time.

Case Study: Yervoy
After others had failed and with time running short, Bristol-Myers Squibb turned to Zenmark to name a new melanoma drug. Our concise solution, Yervoy, is pronounced nearly identically in all languages. A huge advantage in marketing efficiency. Read on. »